Search Results - Alexander Coltoff
- Showing 1 - 3 results of 3
-
1
Fedratinib in 2025 and beyond: indications and future applications by Alexander Coltoff, John Mascarenhas
Published in Blood Advances (2025-04-01)Get full text
Article -
2
Outcomes of older patients with TP53-mutated myeloid neoplasms by Omer Jamy, Mobachir El Kettani, Kashish Shah, Rory M. Shallis, Kendall Diebold, Alexander Coltoff, Aaron D. Goldberg, Anand Patel, Jan P. Bewersdorf, Charles Foucar, Yasmin Abaza, Neil Palmisiano, Adam S. DuVall, Vamsi Kota, Shyam A. Patel, Amer M. Zeidan, Ehab Atallah, Mark R. Litzow, Talha Badar
Published in Blood Cancer Journal (2025-10-01)Get full text
Article -
3
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults by Ethan J. Harris, Diren Arda Karaoglu, Madina Sukhanova, Yasmin Abaza, Theodoros Karantanos, Ann-Kathrin Eisfeld, Clare Anderson, Chenyu Lin, Yenny A. Moreno Vanegas, Talha Badar, Alexander Coltoff, Todd C. Knepper, Neval Ozkaya, Hamed Rahmani Youshanlouei, Sinan Cetin, Anand A. Patel, Adam S. DuVall, Michael W. Drazer, Peng Wang, Melissa Tjota, Jeremy P. Segal, Girish Venkataraman, Sandeep Gurbuxani, Jason X. Cheng, Daniel A. Arber, Richard A. Larson, Olatoyosi Odenike, Jonathan Webster, Bijal Shah, Wendy Stock, Caner Saygin
Published in Blood Cancer Journal (2025-08-01)Get full text
Article
